Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03002571 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)
A Phase 3 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 3
- Development phase
- 338
- Enrollment target
NCT03002571 is a Phase 3 study that has completed, run by Bausch Health Americas. The registered enrollment target is 338 participants.
The verdict
NCT03002571, a Phase 3 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 338 participants
- Enrollment target
Study Summary
Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
Interventions
- DRUG IDP-124 Lotion
- DRUG IDP-124 Vehicle Lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2018-07-24 |
| Est. Completion | 2020-04-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03002571
The ClinicalTrials.gov registry entry for NCT03002571 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IDP-124 Lotion is the first listed.
NCT03002571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03002571 about?
NCT03002571 is a clinical study titled "Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)". Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
What is the current status of trial NCT03002571?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 338 participants. The study started on 2018-07-24. Estimated completion is 2020-04-14.
What interventions are being tested in trial NCT03002571?
The interventions under investigation include: IDP-124 Lotion (DRUG), IDP-124 Vehicle Lotion (DRUG).
Who is sponsoring clinical trial NCT03002571?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.